Wuhan Keqian Biology Co Ltd Class A 688526
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CN¥12.15
- Day Range
- CN¥12.15–12.35
- 52-Week Range
- CN¥11.65–18.00
- Bid/Ask
- CN¥12.32 / CN¥12.34
- Shares Outstanding
- 466.13M
- Market Cap
- CN¥5.75B
- Volume/Avg
- 1M / 2M
Key Statistics
- Price/Earnings (Normalized)
- 21.60
- Price/Sales
- 6.83
- Dividend Yield (Trailing)
- 5.19%
- Dividend Yield (Forward)
- 5.19%
- Dividend Payment Schedule
- May
- Total Yield
- 5.19%
Company Profile
Wuhan Keqian Biology Co Ltd is engaged in Research and development, production, and sales of veterinary biological products, as well as animal disease prevention and control technical services.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 950
- Website
- http://www.kqbio.com
Valuation
|
Metric
|
688526
|
|---|---|
Price/Earnings (Normalized) | 21.60 |
Price/Book Value | 1.43 |
Price/Sales | 6.83 |
Price/Cash Flow | 15.12 |
Price/Earnings
688526
Financial Strength
|
Metric
|
688526
|
|---|---|
Quick Ratio | 5.53 |
Current Ratio | 7.82 |
Interest Coverage | — |
Quick Ratio
688526
Profitability
|
Metric
|
688526
|
|---|---|
Return on Assets (Normalized) | 5.35% |
Return on Equity (Normalized) | 6.02% |
Return on Invested Capital (Normalized) | 5.05% |
Return on Assets
688526
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|Z<xG!YQ | LOCK|f&r#P | $128B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|#g#Yp@ | LOCK|>%%J< | $76B | |||
| Moderna Inc
MRNA
| LOCK|sL<Hrm | LOCK|gf | $75B | |||
| argenx SE ADR
ARGX
| LOCK|$@Qs@@ | LOCK|^Y | $60B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|Rc%ZbS> | LOCK|S&S | $44B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|&?hSl?K | LOCK|qSbjt | $31B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|&w#@$$! | LOCK|f%>zx | $26B | |||
| BioNTech SE ADR
BNTX
| LOCK|!#CDWRj | LOCK|W^q | $24B | |||
| Incyte Corp
INCY
| LOCK|hSRpvB! | LOCK|vt$ | $24B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|%y>#SR^ | LOCK|>@ | $15B |
United States